Hepatitis C and Renal Transplantation in the Era of Modern Immunosuppression

Hepatitis C Virus Infection

2001 • 2,979 citations

Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C

2000 • 885 citations

Survival in Recipients of Marginal Cadaveric Donor Kidneys Compared with Other Recipients and Wait-Listed Transplant Candidates

2001 • 855 citations

Effect of the Use or Nonuse of Long-Term Dialysis on the Subsequent Survival of Renal Transplants from Living Donors

2001 • 465 citations

A comparison of fibrosis progression in chronic liver diseases

2003 • 456 citations

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

2003 • 418 citations

Hepatitis C in the HIV-Infected Person

2003 • 412 citations

Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease

1998 • 316 citations

Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention.

2003 • 314 citations

Validation of Comorbid Conditions on the End-Stage Renal Disease Medical Evidence Report

2000 • 297 citations

Electrocardiographic Left Ventricular Hypertrophy in Renal Transplant Recipients

2003 • 190 citations

Comprehensive Analysis of CD8⁺-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities

2002 • 188 citations

Improved Detection of Anti‐HCV in Post‐Transfusion Hepatitis by a Third‐Generation ELISA

1995 • 177 citations

Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1

2003 • 166 citations

INCREASED IMMUNOSUPPRESSIVE VULNERABILITY IN ELDERLY RENAL TRANSPLANT RECIPIENTS1,2

2000 • 165 citations

Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration1

2003 • 139 citations

Impact of immunosuppressive therapy on recurrence of hepatitis C

2002 • 124 citations

Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival.

2001 • 115 citations

The expanded criterial donor dilemma in cadaveric renal transplantation

2003 • 112 citations

Effect of Donor Factors on Early Graft Survival in Adult Cadaveric Renal Transplantation

2002 • 94 citations

HEPATITIS C ANTIBODY STATUS AND OUTCOMES IN RENAL TRANSPLANT RECIPIENTS

2001 • 94 citations

Hepatitis C Virus Core Protein Leads to Immune Suppression and Liver Damage in a Transgenic Murine Model

2002 • 83 citations

Donor Hepatitis C Seropositivity

2002 • 82 citations

The Addition of Mycophenolate Mofetil to Antiretroviral Therapy Including Abacavir Is Associated With Depletion of Intracellular Deoxyguanosine Triphosphate and a Decrease in Plasma HIV-1 RNA

2002 • 81 citations

Association between hepatitis C infection and other infectious diseases: a case for targeted screening?

2003 • 79 citations

Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus)

2002 • 78 citations

Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir

2002 • 74 citations

Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation

2002 • 71 citations

Performance of three generations of anti‐hepatitis C virus enzyme‐ linked immunosorbent assays in donors and patients

1997 • 56 citations

Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infection

2003 • 55 citations

Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees

2002 • 48 citations

Immunosuppression in Elderly Renal Transplant Recipients

2001 • 43 citations

Death after graft loss: a novel endpoint for renal tranplantation

2001 • 42 citations

Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays)

1995 • 41 citations

Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C

2002 • 34 citations

First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCV

2002 • 32 citations

Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays

2002 • 30 citations

Recurrence of hepatitis c in liver transplant recipients treated with mycophenolate mofetil

2002 • 29 citations

Short-term combination of mycophenolate mofetil with cyclosporine as a therapeutic option for renal transplant recipients

2002 • 27 citations

Policies concerning the use of kidneys from donors infected with hepatitis C virus

2000 • 26 citations

The impact of renal transplantation on the incidence of congestive heart failure in patients with end-stage renal disease due to diabetes.

2001 • 20 citations

Delay of hepatitis c recurrence in liver transplant recipients: impact of mycophenolate mofetil on transplant recipients with severe acute rejection or with renal dysfunction

2002 • 17 citations

Soluble CD-4 and CD-8 as markers of immunological activation in renal transplant recipients

2000 • 16 citations

Mycophenolate mofetil is associated with less death with function than azathioprine in cadaveric renal transplantation

2003 • 15 citations

Mycophenolate’s influence in the treatment of recurrent hepatitis c following liver transplantation

2002 • 14 citations

Induction immunosuppression for patients who underwent transplantation for cirrhosis caused by hepatitis C? The answer is no!

2002 • 7 citations

Rapid liver failure related to chronic C hepatitis in an HIV seropositive hemophilic patient with severe immunodepression.

1996 • 4 citations